Part of the debate – in the House of Lords at 2:59 pm on 27 February 2023.
Lord Parkinson of Whitley Bay
Parliamentary Under Secretary of State (Department for Culture, Media and Sport)
2:59,
27 February 2023
My Lords, the UK is a prime location to research, develop and manufacture pharmaceutical products, particularly complex medicines. The Life Sciences Vision acknowledges that there has been a long-term decline in medicines manufacturing in the UK over the past quarter of a century, as the noble Lord highlighted in his Question, but official statistics from the Office for Life Sciences show that employment in core biopharmaceutical manufacturing has increased by 5% in the two years from 2019. The UK holds the number one spot for life science investment in Europe, and globally is second only to the US, so there are reasons for optimism as well.